Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines

Cefuroxime Axetil and Potassium Clavulanate Tablets, 625 mg

₹ 7,900/Box

Strength625 mg
FormulationCefuroxime
Dosage FormTablet
Packaging Size10*1*10 Tablets, 1*10 Tablets
Pack TypeBox
Packaging TypeBox
FormTablets
ManufacturerKrishgir Pharmaceuticals Private Limited
Brand NameCureme-CV
CompositionCefuroxime Axetil and Potassium Clavulanate
TreatmentBacterial Infections
AvailabilityIn Stock
View in Hindi Cefuroxime Axetil and Potassium Clavulanate टैबलेट्स, 625 mg

CEFUROXIME+CLAVULANIC ACID belongs to the group of medicines called antibiotics used to treat various bacterial infections such as pharyngitis/tonsillitis (throat infections), otitis media (ear infections), sinusitis (infection of the sinuses), gonorrhoea (sexually transmitted disease), Lyme disease, septicaemia

Find products similar to Cefuroxime Axetil And Potassium Clavulanate Tablets, 625 Mg

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromPanchkula
ShippingAs per delivery location

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
02-03-2020
Legal Status of Firm
Limited Company
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
5 - 25 Cr
IndiaMART Member Since
Mar 2022
GST
06AAGCK2741R1Z3

Established in year 2010 , We “Krishgir Pharmaceuticals Private Limited.” are Manufacture , Service Provider of an Pharmaceutical Tablets, Pharmaceutical Capsules, Tablets ,Pharmaceutical Injection etc . We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.


For our accomplishment story, we are grateful to our Mrs Kiran Kumari whose continual backing and direction have been useful to us for attaining exponential development in the current market.